G.L. Pharma GmbH Strategic SWOT Analysis Review [Updated: 08022017] Prices from USD $125

04:16 EST 2 Mar 2017 | BioPortfolio Reports

G.L. Pharma GmbH Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.
Corporate strategy GlobalData's summarization of the company's business strategy.
SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities A list of key manufacturing facilities of the company.


G.L. Pharma GmbH G.L. Pharma is a pharmaceutical company that provides a product mix of novel pharmaceutical drugs and branded generic drugs. The company's core competence concentrates on three different business areas, namely, cardiovascular system; central nervous system CNS; and urology, cancer and opioid substitution therapy. It also has various products under development for treating vitamin B1 deficiency, opioid use disorder, severe pain, narcotic, epilepsy, overactive bladder, moderate pain, nausea, emesis and muscle spasms. G.L. Pharma distributes its products to several markets worldwide with its own marketing structures in Austria and Eastern Europe. The company has stateoftheart production sites in Lannach, Graz, Austria and Vienna, Austria. G.L. Pharma is headquartered in Lannach, Austria.

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.
Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: G.L. Pharma GmbH Strategic SWOT Analysis Review [Updated: 08022017] Prices from USD $125


More From BioPortfolio on "G.L. Pharma GmbH Strategic SWOT Analysis Review [Updated: 08022017] Prices from USD $125"

Quick Search


Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...